Edition:
United Kingdom

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

1.77USD
12 Oct 2018
Change (% chg)

$0.02 (+1.14%)
Prev Close
$1.75
Open
$1.79
Day's High
$1.81
Day's Low
$1.75
Volume
29,548
Avg. Vol
87,498
52-wk High
$8.61
52-wk Low
$1.41

Chart for

About

Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. It has developed the Disease Relevant... (more)

Overall

Beta: --
Market Cap(Mil.): $55.48
Shares Outstanding(Mil.): 25.10
Dividend: --
Yield (%): --

Financials

  PTI.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -2.19 -- --
ROI: -123.49 1.70 14.60
ROE: -127.78 3.17 16.33

BRIEF-Proteostasis Therapeutics Says CFO Helen Boudreau Provided Notice Of Resignation

* PROTEOSTASIS THERAPEUTICS SAYS ON MAY 2, CFO AND TREASURER, HELEN BOUDREAU, PROVIDED NOTICE OF RESIGNATION TO PURSUE ANOTHER PROFESSIONAL OPPORTUNITY

07 May 2018

Earnings vs. Estimates